Japan's top drugmaker Takeda Pharmaceutical has faced at least nine trials since 2013 over claims that it tried to cover up its diabetes drug Actos' cancer risks. The company has offered (Dollar) 2.2 billion to settle more than 8,000 lawsuits linked to Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday. A Tokyo-based spokesman for Takeda Pharmaceutical declined to discuss the lawsuits or comment on Wednesday's report. The ...Sunday 5 April 2015
Japan's Takeda Offers (Dollar) 2.2 Billion to Settle US Lawsuits Linked to Diabetes Drug Actos
Japan's top drugmaker Takeda Pharmaceutical has faced at least nine trials since 2013 over claims that it tried to cover up its diabetes drug Actos' cancer risks. The company has offered (Dollar) 2.2 billion to settle more than 8,000 lawsuits linked to Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday. A Tokyo-based spokesman for Takeda Pharmaceutical declined to discuss the lawsuits or comment on Wednesday's report. The ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment